Clinical Trials Browser

Phase 2 × Bile Duct Neoplasms × ceralasertib × Clear all

NCT04298008 2024-04-19

AZD6738 Plus Durvalumab in Biliary Tract Cancer

Phase 2 Recruiting

Gastrointestinal

Bile Duct Neoplasms

NCT04298021 2024-04-19

DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer

Phase 2 Active not recruiting

Gastrointestinal

Bile Duct Neoplasms